The Diplomatic Envoy

WHO

2021November 2021International News

WHO Rejects Turkmenistan’s Zero-COVID Claim

The government of Turkmenistan continues to claim it is free of the COVID-19 pandemic, despite growing backlash from opposition groups abroad and a visit from the World Health Organization (WHO). The Central Asian former Soviet Republic is one of nine nations that has yet to report a single COVID-19 case, according to ABC News.

Read More
September 2021Opinion

China’s Authoritarianism Facilitated Its Economic Victory Over COVID-19

Despite being the epicenter of the COVID-19 outbreak, China’s swift and strict response to the pandemic allegedly led to a 2.3 percent increase in GDP in the year 2020, reports NPR. The pandemic posed a unique challenge for the communist government, but not an unmanageable one. Leaning into authoritarian tactics, the Chinese government  was able to fight the virus while simultaneously building back its economy.

Read More
2021March 2021FocusVaccine DiplomacyAsia

FOCUS on Vaccine Diplomacy: India

Since the beginning of the COVID-19 pandemic, developing countries faced long delays obtaining access to vaccines due to vaccine nationalism and hoarding by rich countries. To fill the gap, India has emerged as a ‘vaccine superpower’ and source of hope to poorer countries, which are unable to access vaccines due to their high cost and unavailability. India is offering governments in developing nations both the locally-manufactured British AstraZeneca vaccine and its own home-grown vaccine, Covaxin. 

Read More
2021WorldFebruary 2021International NewsAmericas

Canada to Take Vaccines from COVAX

Canada is defending its decision to accept coronavirus vaccines from COVAX, a program developed to help low- and middle- income countries with the vaccination process. According to The Washington Post, Deputy Prime Minister Chrystia Freeland stated that the Canadian government “will never apologize” for doing what they can to vaccinate Canadians alongside the rest of the world.

Read More
December 2020International News2020

Companies Seek Vaccine Approval as COVID-19 Cases Rise

On Tuesday, November 30, biopharmaceutical firms BioNTech and Moderna applied for approval of their respective COVID-19 vaccines in the European Union (EU), The Wall Street Journal reports. National Geographic says the EU is expected to conclude Pfizer’s assessment by December 29 and Moderna’s by January 12. Both Moderna and Pfizer Inc. also applied for emergency usage of their vaccines in the United States at the end of November, though it is unclear when a decision will be made.

Read More